Celgene Corp (CELG)

CELG (NASDAQ:Drugs) EQUITY
$116.78
pos +0.00
+0.00%
Today's Range: 116.35 - 117.18 | CELG Avg Daily Volume: 3,537,900
Last Update: 05/26/17 - 4:00 PM EDT
Volume: 0
YTD Performance: 0.89%
Open: $0.00
Previous Close: $116.74
52 Week Range: $94.42 - $127.64
Oustanding Shares: 780,824,335
Market Cap: 91,153,432,868
6-Month Chart
TheStreet Ratings Grade for CELG
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 13 15 15 15
Moderate Buy 0 0 0 0
Hold 3 2 2 2
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.38 1.24 1.24 1.24
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: 43.89
Price Earnings Comparisons:
CELG Sector Avg. S&P 500
43.89 43.90 29.90
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
-1.23% 10.40% 55.57%
GROWTH 12 Mo 3 Yr CAGR
Revenue 21.30 0.70 0.20
Net Income 24.80 0.40 0.11
EPS 28.40 0.50 0.14
Earnings for CELG:
EBITDA 3.71B
Revenue 11.23B
Average Earnings Estimates
Qtr (06/17) Qtr (09/17) FY (12/17) FY (12/18)
Average Estimate $1.61 $1.70 $6.62 $8.22
Number of Analysts 7 7 8 4
High Estimate $1.67 $1.77 $6.77 $8.44
Low Estimate $1.54 $1.67 $6.49 $7.91
Prior Year $1.28 $1.39 $5.18 $6.62
Growth Rate (Year over Year) 26.12% 22.51% 27.78% 24.19%
Chart Benchmark
Average Frequency Timeframe
Indicator Chart Scale  
Symbol Comparison Bollinger Bands
RMPIA
By

Ed Ponsi

 | May 26, 2017 | 10:00 AM EDT
Time to revisit some stocks now that biotech has cooled.
RMPIA
By

Bret Jensen

 | May 24, 2017 | 11:30 AM EDT
Valuations in some large-caps are compelling over the long term.
RMPIA
By

Doug Kass

 | May 22, 2017 | 4:02 PM EDT
"Success breeds complacency. Complacency breeds failure. Only the paranoid survive." - Andy Grove   Perhaps this qu …
RMPIA
By

Bret Jensen

 | May 14, 2017 | 10:00 AM EDT
These names are now undervalued, despite solid results and good fundamentals.
RMPIA
By

Bret Jensen

 | May 12, 2017 | 11:30 AM EDT
These names are now undervalued, despite solid results and good fundamentals.
RMPIA
By

Doug Kass

 | May 8, 2017 | 4:38 PM EDT
"She's a witch of trouble in electric blue, In her own mad mind she's in love with you. With you. Now what you gonna do? Strange brew, kill w …
RMPIA
By

Doug Kass

 | May 8, 2017 | 12:33 PM EDT
Allergan (AGN) , a day ahead of its earnings release, is down by over $4 on no apparent news, save a rotation out of biotech. (iShares Nasdaq Biotechnology (IBB) is -3% or -$7 and we see individual equity declines in Celgene (CELG) , Gilead (GILD) , Acadia Pharmaceuticals (ACAD) , Aerie Pharmaceuticals (AERI) , and Intrexon (XON) ).
RMPIA
By

Bret Jensen

 | May 3, 2017 | 11:40 AM EDT
How did Celgene, AbbVie and Gilead fare last quarter?
RMPIA
By

Robert Lang

 | Apr 27, 2017 | 10:00 AM EDT
This stock is poised for more upside.
RMPIA
By

Bret Jensen

 | Apr 27, 2017 | 8:49 AM EDT
It is hard to keep up with the flurry of first-quarter earnings reports hitting the wires this morning. Here are a few that caught my eye today.
DIS has been green since the opening bell and is trading at its best levels of the week wi...
Looks like RUTH will finish the week at new 2017 highs.  Still has room to run, not o...
A big THANK YOU to all the men and women in uniform this weekend, and for those who served...

REAL MONEY PRO'S BEST IDEAS

News Breaks

Powered by
Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.